Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ehlken

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 17, 2013
[Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD. A cost-effectiveness analysis for Germany]D Nowak, B Ehlken, R Kotchie, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 23, 2006
Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in GermanyB Brüggenjürgen, P Lindgren, B Ehlken, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 31, 2002
Prospective population-based study on rotavirus disease in GermanyB Ehlken, B Laubereau, W Karmaus, et al.
The European Respiratory Journal|February 7, 2003
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective studyB Schramm, B Ehlken, A Smala, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 18, 2010
Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 monthsD Thaci, C Chambers, M Sidhu, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 4, 2005
[Cost-of-illness study in patients suffering from atopic eczema in Germany]B Ehlken, M Möhrenschlager, B Kugland, et al.
Revista De Neurologia|November 26, 2021
Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe, analysis of data from SpainB Ehlken, I Stevanovic, S Kaplan, et al.
The Pediatric Infectious Disease Journal|February 27, 2001
Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in AustriaM Frühwirth, K Berger, B Ehlken, et al.
Journal of Medical Economics|November 1, 2011
Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in GermanyL Breitscheidel, B Ehlken, K Kostev, et al.
Schweizerische Medizinische Wochenschrift|December 28, 1999
[Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group]B Laubereau, S Gateau, B Ehlken, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|January 17, 2013
[Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD. A cost-effectiveness analysis for Germany]D Nowak, B Ehlken, R Kotchie, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 23, 2006
Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in GermanyB Brüggenjürgen, P Lindgren, B Ehlken, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 31, 2002
Prospective population-based study on rotavirus disease in GermanyB Ehlken, B Laubereau, W Karmaus, et al.
The European Respiratory Journal|February 7, 2003
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective studyB Schramm, B Ehlken, A Smala, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 18, 2010
Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 monthsD Thaci, C Chambers, M Sidhu, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 4, 2005
[Cost-of-illness study in patients suffering from atopic eczema in Germany]B Ehlken, M Möhrenschlager, B Kugland, et al.
Revista De Neurologia|November 26, 2021
Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe, analysis of data from SpainB Ehlken, I Stevanovic, S Kaplan, et al.
The Pediatric Infectious Disease Journal|February 27, 2001
Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in AustriaM Frühwirth, K Berger, B Ehlken, et al.
Journal of Medical Economics|November 1, 2011
Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in GermanyL Breitscheidel, B Ehlken, K Kostev, et al.
Schweizerische Medizinische Wochenschrift|December 28, 1999
[Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group]B Laubereau, S Gateau, B Ehlken, et al.
Pageof 2